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Objectives: Suicidal behavior (SB) is a major cause of mortality for patients diagnosed with bipolar disorder (BD). In this study, we investigated epigenetic differences in BD participants with and without a history of SB.
Methods:
We used suicidality scores constructed from Schedule for Clinical Assessments in Neuropsychiatry (SCAN) interview questions about suicidal thought and behavior to identify individuals from a BD cohort of n=452; participants with the most extreme high (H-SB, n=18) and most extreme low (L-SB, n=22) scores were used as cases and controls, respectively. Epigenome-wide DNA methylation patterns were compared between the two groups using the Illumina Infinium Human Methylation 450 BeadChip microarray. DNA methylation age was compared to chronological tissue age.
Results:
We observed highly significant differences in methylation between cases and controls in three genomic regions enriched for epigenetic modifications corresponding to gene regulatory regions. BD participants with a history of SB showed less overall methylation in the 5′ untranslated region of Membrane palmitoylated protein 4 (MPP4) (P=7.42×10 −7 ) and in intron 3 of TRE2/BUB2/CDC16 domain family member 16 (TBC1D16) (P=6.47×10 −7 ), while exon 1 of Nucleoporin 133 (NUP133) was less methylated in controls (P=1.17x10 -6 ). Moreover, we observed a greater correlation between DNA methylation age and tissue age in controls (r=.91, P<.0001) than in the H-SB group (r=.83, P<.0001).
Conclusions:
We report significant findings at three loci based on a methylome scan of participants with BD for an SB phenotype, and potentially altered molecular aging in suicide attempters. Despite the small sample size, our proof-of-concept study highlights the potential for epigenetic factors to be useful in understanding the molecular underpinnings of suicide with the ultimate aim of its prevention.
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| INTRODUCTION
Individuals with bipolar disorder (BD) are at significant risk of suicidal behavior (SB), a spectrum which includes ideation, attempt and completion. 1 More than half of all individuals with BD have at least one lifetime suicide-related disturbance, and 8−20% are at risk of completed suicide. 2, 3 A history of suicide attempt is associated with long-term disability and negative health outcomes. 4, 5 Clinical and molecular findings support the idea that transmission of SB in mood and affective disorders has a familial and environmental basis, 6, 7 whereby predictive factors are described as proximal, such as substance use, mood disorders and adherence to treatment, and distal, such as a family history of SB and adverse childhood experiences.
Suicidal ideation and completion have also been associated with candidate genes that mediate stress response and neurotransmis- These regions were annotated with chromatin modification profiles of peripheral blood and post-mortem brain to investigate the concordance of epigenetic marks across these tissues. Based on previous epigenetic studies of SB, we expected that individuals with BD and a history of suicidality may be at a greater risk of trauma and heightened sensitivity to stressful events, which may be reflected in distinct DNA modification changes compared to BD patients without a history of suicidality.
| METHODS

| Patient recruitment and sample collection
Individuals were chosen from a larger sample of BD patients from 
| DNA and genotyping
Genomic DNA was obtained from white blood cells using a high salt extraction method. Table S1 .
| Data analysis
Preliminary methylome analysis was performed using the Illumina GenomeStudio software, which yields a β value, a measure of the density of methylated cytosines for each locus. Background intensities were used to normalize the data set. The β value was then calculated as the intensity of methylated probes divided by the sum of the intensity of methylated probes and the intensity of unmethylated probes; β values range between 0 (unmethylated) and 1 (fully methylated). Individual CpGs were analyzed for differences between case and control groups. Further, methylation values were combined for CpG sites in the same genomic region. Subsequent analysis was performed using a modified version of the IMA R package. 19 Peak correction was done to normalize methylation levels detected by probes of the array. 20 Eight samples, containing more than 5% of probes with a detection P-value >.00001, were removed. The detection P-value is defined as the probability that the probe intensity is distinguishable from the background intensity. Forty samples (18 cases and 22 controls) were retained from the original set, and underwent quality control and data cleaning. As a quality control measure, any samples that showed outlier signals for any of the internal array control probes (which were used to assess the quality of bisulfite conversion, hybridization, single base extension, target removal, and non-specific probe extension) were removed from further analysis; no sample was removed from this step. frontal lobe, and substantia nigra) and two blood cell types (naïve CD4 and CD8 T cells). 24 Regions of interest were mapped to enrichment data using the Genboree Workbench tool. 25 Values corresponding to histone enrichment in peripheral blood and brain tissue were averaged for all CpGs of a given region, and graphed based on the magnitude of relative enrichment using Excel (Microsoft).
Quality control of SNP genotyping data was performed using PLINK and R in a fashion similar to that described in Zai et al. 18, 26 SNPs within and 10 kb upstream and downstream of the three significant regions were profiled. Individuals and SNPs with more than 1% missing genotypes were excluded. SNPs with minor allele frequencies of <.01 were removed. We did not find related individuals (PI_HAT >.05) or participants with extreme heterozygosity (<4 SD from the mean). SNPs for which the genotypes deviate from Hardy−Weinberg equilibrium (P<.000001) were not included. Fiftytwo markers remained after additional quality control for missingness and minor allele frequency for the 32 individuals included in the case−control association analysis.
| RESULTS
We investigated peripheral blood DNA methylation states in individuals diagnosed with BD who were grouped as controls and cases on the basis of extreme scores on a modified SSU. 15 We observed age-adjusted epigenome-wide significant case−control differences (an NSHORE region encompassing cg02238387, cg16461139, cg17578309, cg26379012 and cg26940676) was less methylated in cases (Δβ=.027; P=.013). These findings are summarized in Figure 1 .
Moreover, we report several differentially methylated individual CpGs and CpG clusters between suicide and non-suicide groups which were significant in our preliminary analyses (P<.05−.0001), but did not reach epigenome-wide significance (Table S2) . We also used previously available SNP genotyping data for 32 of our participants in and near the three significant regions presented above and found several nominally significant alleles with a case−control association (Table S3) .
Next, we compared tissue age and blood cell type distribution between case and control groups based on DNA methylation in biological age-associated regions. Using the DNA methylation age calculator, we observed that the DNA methylation age of tissue was more closely correlated with biological patient age in non-suicide control patients (r=.919, P<.0001, standard error=6.411 years; Figure 2A 
| DISCUSSION
We interrogated the DNA methylation state of nearly 350 000 CpGs, and found significant differential methylation in three gene regions between individuals diagnosed with BD who were grouped on the basis of extremes of suicidality scores (SSU). We annotated the identified markers with histone modification enrichment data from brain and F I G U R E 1 Summary of significantly differentially methylated regions between suicide (Sui) and control groups adjusted for false discovery rate (FDR) using Benjamini-Hochberg (BH) correction. Top graphs, age-adjusted box plots of methylation difference; middle graphs, quantilequantile plots of the association between DNA methylation and group in the significant gene region; bottom graphs, Manhattan plots of the association between DNA methylation and group in the significant gene region. 
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Second, we observed differential case−control methylation at exon 1 of NUP133. The NUP133 protein is a member of a complex involved in the cell cycle, and plays a role in spindle assembly, kinetochore function, cytokinesis, nuclear pore complex reassembly following mitotic exit and de novo nuclear pore complex assembly in interphase, and helps mediate nuclear mRNA export. in the hippocampus and CD8 T cells. 42 These findings may be of relevance to our study given the role that the TBC1D16 protein plays as a GTPase activator of the Ras-related protein 4a (Rab4a) signaling pathway. 43 This pathway modulates the trafficking and activity of the epidermal growth factor receptor (EGFR), a signaling receptor kinase that is involved in neural cell growth and survival, and was shown to exhibit crosstalk with tropomyosin receptor kinase B (TrkB). In the brain, TrkB is involved in neurotransmission, synaptic plasticity and neuronal integrity, and has been widely implicated in modulating the course and symptoms of BD along with its ligand brain-derived neurotrophic factor. 44 For instance, reduced levels of TrkB protein in frontal cortex astrocytes of suicide completers were attributed to hypermethylation of the 3′ UTR of a truncated TrkB transcript. 11 Moreover, an SNP in EGFR was found to be significant in a genome-wide association study of BD, 45 but this finding was not supported by a subsequent study.
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Based on these data, we posit that DNA methylation of TBC1D16 may influence neuronal and astrocytic cellular stability through protein−protein interactions with TrkB, and could be a molecular marker that is reflective of a history of suicidal behavior. Our findings are corroborated by a recent study of panic-induced epigenetic modifications in mice. Notably, the latter two most significant loci described above are . 47 Moreover, three nominally significant genes in our study are significantly differentially modified in panic mouse models (PPTC7, PIWI1 and GNAS). Given the strong concordance between suicide attempt and panic disorder, these loci may be part of a common molecular pathway involved in both processes. 48, 49 We extended our analysis by investigating age-related signatures of DNA methylation as a product of SB in our patient group. Using the freely available DNA methylation age calculator, 23 we compared chronological age of sample tissue at collection date to its corresponding DNA methylation age, and observed a weaker correlation between these two variables in H-SB individuals compared to controls. Based on the observed case−control differences, we hypothesize that blood tissue in individuals with a history of suicide attempt may exhibit greater age acceleration, a measure of the discrepancy between epigenetic and chronological age. This marker is posited to be a predictor of regulatory and genomic stability. For instance, aberrant age acceleration was observed in 6000 cancer cell lines, and is thought to impact cell survival. 23 In another study, increased epigenetic aging was associated with somatic mutations of growth and proliferation factors and increased progression of cancer. 50 Taking these findings into consideration, our observation of differential epigenetic age acceleration particularly in middle-aged patients may suggest that While of small individual effect size, this exploratory study nevertheless supports the hypothesis that individuals with BD and a history of SB may be epigenetically distinct from non-suicidal BD patients.
Subsequent studies should focus on validation of the newly identified loci using targeted sequencing methods, and further investigation in multiple tissues, including post-mortem brain, to identify their potential role in molecular networks which may predispose to or be reflective of SB.
| CONCLUSION
We surveyed the epigenome by microarray to investigate the symptomatic complexity of suicide in BD, and observed significant epigenetic differences in several regions between BD patients with and without a history of high suicidality scores. This study is also the first to report on molecular aging acceleration effects in tissue from individuals with a history of SB, which may be of importance in improving understanding of molecular changes resulting from suicide attempt. Our findings may be relevant for identification of mutable substrates in pathways linked to suicidal-and stress-related behaviors in the context of mood and affective disorders. Further comparative epigenetic analysis on the basis of SB would improve understanding of the epigenetic interplay between inherited and environmental effects in BD, and provide an improved understanding of the epigenetic pathways that correspond to vulnerability to future SB, with the ultimate goal of preventing this fatal outcome in an already at-risk population.
